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Editorial Comment 
The Continuing Conundrum of 
Syndrome X: Further Evidence 
of Heterogeneity* 
MARTIN A. ALPERT,  MD, FACC 
Mobile, Alabama 
Syndrome X is the term coined by Kemp et al. (1) in 1973 to 
describe patients with angina pectoris and angiographically 
normal coronary arteries. Syndrome X has been the focus of a 
large number of studies during the past 15 years (2). Selection 
criteria for these studies have varied widely, and many have 
included patients with ~pical and atypical angina pectoris, 
hypertensive and normotensive subjects and those with and 
without electrocardiographic (ECG) signs suggestive of isch- 
emia. The most important of these studies have related to 
coronary flow reserve, myocardial metabolism during stress, 
left ventricular function and pain perception. Although these 
studies have failed to provide a unifying hypothesis concerning 
the cause of syndrome X, they have provided important 
insights into the patbogenesis of this enigmatic disorder. 
Pathogenesis ofsyndrome X. Studies by Opherk et al. (3) 
published in 1981 suggested that the apparent presence of 
myocardial ischemia in patients with syndrome X may relate in 
part to impaired coronary flow reserve. Patients with syndrome 
X experienced a more limited increase in coronary blood flow 
after intravenous diwridamole-induced coronary vasodilation 
than normal control subjects (3). A subsequent study by 
Cannon et al. (4) reported a limitation of great cardiac vein 
flow in response to rapid atrial pacing. Intravenous ergonovine 
administration attenuated the increase in great cardiac vein 
flow in patients with typical angina pectoris during rapid atrial 
pacing to a greater extent han in those who did not experience 
chest pain during pacing (4). Minimal coronary resistance was 
also noted to be higher after intravenous dipyridamole infusion 
in those who manifested a vasoconstrictor response to ergono- 
vine than in those who did not (4). 
Cannon et al. (2) used the term microvascular ngina to 
describe patients with syndrome X with apparent enhanced 
sensitivity of the coronary microcirculation tovasoconstrictive 
stimuli and impaired vasodilator coronary reserve. In a study of 
18 patients with syndrome X, LeGrand et al. (5) reported 
lower coronary flow rates in 7 with thallium perfusion defects 
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than in 11 with normal radionuclide perfusion findings. In a 
study of 13 patients with syndrome X, Bortone et al. (6) 
reported exercise-induced constriction of the distal epicardial 
coronary arteries detected by coronary angiography in 6 and 
vasodilation i  the remaining 7, Coronary sinus flow was more 
limited in those patients with exercise-induced distal epicardial 
coronary artery constriction than in those with vasodilation (6). 
Several studies (2) using positron emission tomography and 
oxygen-15 water or nitrogen-I 3 ammonia have reported lower 
myocardial perfusion ratios after dipyridamole-induced vaso- 
dilation in patients with syndrome X and in patients with mild 
coronary atherosclerosis. Thus, patients with syndrome X 
frequently, but not invariably, experience impaired coronary 
vasodilator reserve in response to pacing stress and pharma- 
cologic vasodilation. Although there appears to be some 
relation between clinical/ECG findings suggestive of myocar- 
dial ischemia and impaired coronary vasodilator reserve, there 
is an insufficient degree of concordance to characterize this 
unique microvascular response as the sole mechanism of 
syndrome X. 
Attempts to characterize patients with syndrome X by 
means of metabolic studies have produced conflicting results. 
Kemp et ah (1) and Cannon et al. (2) reported myocardial 
lactate production during isoproterenol stress in 11 of 41 
patients with syndrome X. Opherk et al. (3,7) reported myo- 
cardial lactate production in three of eight patients with 
syndrome X subjected to rapid atrial pacing but none in 
control subjects. Cannon et al. (2,4) observed significantl) 
lower levels of myocardial lactate consumption i patients with 
syndrome X who were classified as having microvasculal 
angina than in those who did not manifest a vasoconstrictor 
response. Notably, lactate production occurred in only 10% of 
patients with microvascular angina (2,4). Camici et al. (8~, 
reported no myocardial lactate production in 11 women wiffL 
syndrome X despite the presence of repolarization abnormal-. 
ities suggestive of ischemia on the exercise ECG. Thus, meta.. 
bolic studies of patients with syndrome X have not provided 
convincing evidence of myocardial ischemia. Lactate produc- 
tion in such patients occurs infrequently. It appears to relate 
primarily to substrate availability and may be a normal re- 
sponse to pacing or pharmacologic stress (2). 
Several studies (2,9,10) have documented deterioration of 
left ventricular systolic function at rest and during exercise 
over time in patients with syndrome X. In one such study (9) all 
patients who had deterioration of left ventricular systolic 
function also had left bundle branch block. In a more recent 
study by Cannon et al. (2), 15 of 61 patients with microvascular 
angina experienced a >10% reduction in left ventricular 
ejection fraction over a follow-up period of 4.5 years. Myocar- 
dial biopsy samples from such patients have revealed nonspe- 
cific findings, such as patchy fibrosis, myocellular hypertropff~, 
and mitochondrial swelling. Given the low incidence of myo- 
cardial ischemia in patients with syndrome X (including those 
with microvascular ngina), the pathogenesis of left ventricular 
systolic dysfunction remains unknown. 
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The lack of convincing evidence of myocardial ischemia in 
most patients with syndrome X has stimulated a search for 
alternative mechanisms to account for chest pain in such 
patients. One such hypothesis that patients with syndrome X
may have abnormal pain perception. This hypothesis i sup- 
ported by the work of Turiel et al. (11), who demonstrated 
lower pain threshold in response to forearm ischemia and 
electrical stimulation i  women with syndrome X than in those 
with coronary atherosclerosis. Subsequent s udies by Shapiro 
et al. (12) and Cannon et al. (2,13) have reported adispropor- 
tionately high frequency of chest pain in response to catheter 
pressure against he right atrial wall and right ventricular apex 
and after intracoronary injection of contrast media. If a lower 
pain threshold oes indeed contribute to the presence of chest 
pain in syndrome X, its pathogenesis is unknown. It has been 
postulated (2) that microvascular constriction causes release of 
adenosine, which in turn produces vasodilation of resistance 
vessels to compensate for proximal constriction. Adenosine 
may stimulate pain receptors whether or not the constrictor 
response was sufficient o produce myocardial ischemia (2). 
Treatment of patients with syndrome X. To date, there is 
no therapy that consistently provides relief of chest pain in 
patients with syndrome X, including those with microvascular 
angina (14). Beta-adrenergic blocking agents and calcium 
channel antagonists (particularly verapamil) have been used as 
therapeutic probes but have not predictably provided symptom 
relief (14). 
The case for heterogeneity. Given the inconsistencies 
noted in the aforementioned studies as well as in other clinical, 
hemodynamic and metabolic investigations of syndrome X, it is 
not difficult to build a case for heterogeneity in the pathogen- 
esis of this disorder. One of the most important factors 
contributing to apparent heterogeneity in the pathogenesis of
syndrome X is the use of coronary angiography to identify. 
patients with the syndrome. Coronary angiography is a reliable 
method of imaging moderate to severe coronary atheroscle- 
rotic lesions, particularly when computer-based quantitation 
techniques are used. However, coronary angiography relies on 
"silhouetting" to define coronary anatomy. It is most fallible in 
characterizing qualitative coronary artery morphology in pa- 
tients with moderate to severe atherosclerotic lesions and in 
characterizing the qualitative and quantitative aspects of epi- 
cardial coronary artery morphology in those with minimal 
coronary atherosclerosis and in those with nonatherosclerotic 
alterations in epicardial coronary arteries. In contrast, intra- 
coronary ultrasound is capable of providing high resolution 
images of the coronary artery wall that are superior to those 
obtained with coronary angiography (15). 
Implications of the present study. In this issue of the 
Journal, Weidermann et al. (16) report the results of their 
study using intracoronary ultrasound to assess epicardial cor- 
onary artery morphology in patients with syndrome X. In 
addition, they evaluated the effect of exercise and beta- 
blockade on intraluminal diameter. Intracoronary ultrasound 
showed three distinct morphologic subgroups in patients with 
angiographically normal coronary arteries: those with normal 
coronary artery morphology, those with intimal thickening and 
those with atherosclerotic plaque (16). Exercise produced 
vasodilation of epicardial coronary arteries in subjects with 
normal coronary arteries but produced vasoconstriction of
epicardial vessels in those with intimal thickening and in those 
with atherosclerosis (16). Intravenous infusion of propranolol 
produced attenuation of the vasodilator response in normal 
subjects and attenuation of vasoconstriction in the subgroups 
with intimal thickening and atherosclerosis (16). Weidermann 
et al. (16) propose that these findings demonstrate anatomic 
and physiologic heterogeneity in patients with syndrome X. 
Although the lack of a normal control group and failure to 
apply standard exercise work loads represent limitations, the 
data are nonetheless compelling and support the authors' 
contention of heterogeneity. The authors did not address the 
issue of the microvascular morphology in the present study and 
indeed could not explore this aspect using current intracoro- 
nary ultrasound catheters. However, their findings do provide 
potent evidence that syndrome X is indeed a heterogenous 
disorder, as had been suggested by previous clinical, hemody- 
namic and metabolic studies. 
Future directions. One of the most intriguing findings in 
the Wiedermann et al. (16) study is the presence of intimal 
thickening in some patients with syndrome X. Although mild 
intimal thickening may occur with aging, the degree of thick- 
ening observed in the present study has previously been 
reported only in cardiac transplant recipients. Its patho- 
genesis and clinical significance is unknown and is deserving of 
further study. It would seem worthwhile to assess the effect of 
other pharmacologic probes (e.g., calcium channel blockers, 
angiotensin-converting e zyme inhibitors, alphal-blockers and 
possibly purinc antagonists) with intracoronary ultrasound in 
patients with syndrome X using the methods described in the 
present study. Finally, it is tempting to suggest hat the 
techniques described by Weidermann et al. (16) might be 
useful in guiding therapy in patients with syndrome X. How- 
ever, correlation of short-term hemodynamic responses to 
pharmacotherapy with long-term clinical improvement would 
be required before such time-intensive and costly interventions 
could be recommended in the clinical setting. 
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